Why, why, why Recombinant??? Simply because you own ABBV stock and do not want to lose money is not sufficient reason write nonsense like the one you just did. bio-similars are good for folks that need lower cos medicines and it is time that the thievery of the big pharma be mitigated and curtailed.
You're very dense to confuse me with the short seller( _) I am a scientist not a trader. I still say that one cannot trust anything coming from Rick Gonzales who is a well documented liar and imposter. That's a fact.
No, I am NOT going to sell a single share of ABBV or ABT.
There is a disconnect between the way I perceive the world around me vs. some other folks. I like to bring forward the most controversial assertions, hypotheses, views to stir the proverbial pot. Most folks here are just dumb traders on both sides of the divide... I don't care for their dogmatic nonsense.
Best to you.
183 US and International patents issued. 91 publications in refereed journals, last one few months ago in Angew. Chemie.
Started 5 companies. What data do you want ex-Volwiler Fellow? They were giving Volwiler Fellowships to some pretty incompetent fellow, you know I am right.
I am not a trader, I am a scientist. best to you, don't have more time for you.
Watch my hear beating fast after reading about your Volwiler Society. You Rottweilers are notoriously incompetent. I turned many of your\Rottweilers when you interviewed at my companies.
BTW, I publish in A.Am. Chem. Soc., Angew. Chemie, etc.
I spent my lifetime in drug discovery. You repeat how experienced you are in this area but.. in my long life as a scientist entrepreneur I have seen my dose of shysters.
You don't strike me as a scientist. You are a marketing p uke
Amgen is very advanced in producing adalimumab biosimilar. Others too. As usual your wishful thinking obscures your mind.
is a disaster for ABBV investors. Here is an excellent analysis:
Fact #1: ABBV paid 21 billion
Fact #2: Closest bidder JNJ offered $18 billion.
Fact #3: that's 3billion difference.
Fact #4: THAT'S NOT CLOSE by any financial criteria.
Now you may GFY.
Bets were close to each other??? 3billion $ is not "close". The capacity of the trolls on this MBfor self-delusion is truly amazing...
Nobody gives a squat of what Bar?rons have to say about ABBV.
The facts are simple: ABBV had a deceptive advertising regarding HepC, raising HUGE expectations among investor suckers who pumped the stock to stratospheric levels of $70 with many investor hallucinating about $100 within few months. Add to it Shire fiasco and the looming expiration of Humira and..what do you expect??/ You get in stock price what it IS.
The HUGE problem with traders, "investors" and other such assorted riffraff is that their collective IQ is that of a mollusk. They pontificate C(R)ap and they know NOTHING.